Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion

As prevalence of depression continues to rise around the world, there remains a stagnation of available treatments as the affected population grows. The subset of treatment-resistant depression also is on the rise highlighting the need for innovative treatments to address this issue. Mesenchymal ste...

Full description

Bibliographic Details
Main Authors: Kyohei Kin, Takao Yasuhara, Cesar V Borlongan, Isao Date
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Brain Circulation
Subjects:
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2018;volume=4;issue=3;spage=128;epage=132;aulast=Kin
_version_ 1819168268705857536
author Kyohei Kin
Takao Yasuhara
Cesar V Borlongan
Isao Date
author_facet Kyohei Kin
Takao Yasuhara
Cesar V Borlongan
Isao Date
author_sort Kyohei Kin
collection DOAJ
description As prevalence of depression continues to rise around the world, there remains a stagnation of available treatments as the affected population grows. The subset of treatment-resistant depression also is on the rise highlighting the need for innovative treatments to address this issue. Mesenchymal stem cells (MSCs) have been reported to attenuate depression-like behaviors, however, the effects of encapsulation of MSCs have yet to be investigated. Encapsulation of MSCs exhibited prolonged survival of exogenous cell injection accompanied with increased secretion of neurotrophic factors including vascular endothelial growth factor, ciliary neurotrophic factor, and others. The enhanced expression of these factors highlights the ability of encapsulated MSCs to upregulate the respective signaling pathways, which are associated with depression pathology and activation of neurogenesis. This treatment identifies a promising therapeutic option for depression, specifically treatment-resistant depression. Further, evaluation of long-term effects of the treatment is warranted. This paper is a review article. Referred literature in this paper has been listed in the references section. The datasets supporting the conclusions of this article are available online by searching various databases including PubMed. Some original themes in this article come from the laboratory practice in our research center and the authors' experiences.
first_indexed 2024-12-22T19:00:55Z
format Article
id doaj.art-65d6508060d2444b90d59206e2187411
institution Directory Open Access Journal
issn 2394-8108
2455-4626
language English
last_indexed 2024-12-22T19:00:55Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Brain Circulation
spelling doaj.art-65d6508060d2444b90d59206e21874112022-12-21T18:15:57ZengWolters Kluwer Medknow PublicationsBrain Circulation2394-81082455-46262018-01-014312813210.4103/bc.bc_17_18Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretionKyohei KinTakao YasuharaCesar V BorlonganIsao DateAs prevalence of depression continues to rise around the world, there remains a stagnation of available treatments as the affected population grows. The subset of treatment-resistant depression also is on the rise highlighting the need for innovative treatments to address this issue. Mesenchymal stem cells (MSCs) have been reported to attenuate depression-like behaviors, however, the effects of encapsulation of MSCs have yet to be investigated. Encapsulation of MSCs exhibited prolonged survival of exogenous cell injection accompanied with increased secretion of neurotrophic factors including vascular endothelial growth factor, ciliary neurotrophic factor, and others. The enhanced expression of these factors highlights the ability of encapsulated MSCs to upregulate the respective signaling pathways, which are associated with depression pathology and activation of neurogenesis. This treatment identifies a promising therapeutic option for depression, specifically treatment-resistant depression. Further, evaluation of long-term effects of the treatment is warranted. This paper is a review article. Referred literature in this paper has been listed in the references section. The datasets supporting the conclusions of this article are available online by searching various databases including PubMed. Some original themes in this article come from the laboratory practice in our research center and the authors' experiences.http://www.braincirculation.org/article.asp?issn=2394-8108;year=2018;volume=4;issue=3;spage=128;epage=132;aulast=KinAnimal modeldepressiongrowth factorsmesenchymaltransplantation
spellingShingle Kyohei Kin
Takao Yasuhara
Cesar V Borlongan
Isao Date
Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
Brain Circulation
Animal model
depression
growth factors
mesenchymal
transplantation
title Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
title_full Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
title_fullStr Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
title_full_unstemmed Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
title_short Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion
title_sort encapsulated stem cells ameliorate depressive like behavior via growth factor secretion
topic Animal model
depression
growth factors
mesenchymal
transplantation
url http://www.braincirculation.org/article.asp?issn=2394-8108;year=2018;volume=4;issue=3;spage=128;epage=132;aulast=Kin
work_keys_str_mv AT kyoheikin encapsulatedstemcellsamelioratedepressivelikebehaviorviagrowthfactorsecretion
AT takaoyasuhara encapsulatedstemcellsamelioratedepressivelikebehaviorviagrowthfactorsecretion
AT cesarvborlongan encapsulatedstemcellsamelioratedepressivelikebehaviorviagrowthfactorsecretion
AT isaodate encapsulatedstemcellsamelioratedepressivelikebehaviorviagrowthfactorsecretion